10-Q Filing

IDEXX LABORATORIES INC /DE CIK: 874716 Q1 2016

Filing Information

Form Type	10-Q
Accession Number	`0000874716-16-000026`
Period End Date	20160331
Filing Date	20160429
Fiscal Year	2016
Fiscal Period	Q1
XBRL Instance	c716-20160331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 83 Income Statement 44 Cash Flow Statement 60 Comprehensive Income 27

Balance Sheet 83 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, reserves	`AllowanceForDoubtfulAccountsReceivableCurrent`	$5.10M	USD	Point-in-time
Accounts receivable, reserves	`AllowanceForDoubtfulAccountsReceivableCurrent`	$5.13M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	120.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	120.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$182.16M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$322.54M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$128.99M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$132.95M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$213.59M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	102.55M	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$217.62M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	102.24M	shares	Point-in-time
Accounts receivable, net of reserves of $5,100 in 2016 and $5,128 in 2015	`AccountsReceivableNetCurrent`	$188.32M	USD	Point-in-time
Deferred stock units, outstanding	`CommonStockOtherSharesOutstanding`	240,000.00	shares	Point-in-time
Accounts receivable, net of reserves of $5,100 in 2016 and $5,128 in 2015	`AccountsReceivableNetCurrent`	$212.07M	USD	Point-in-time
Deferred stock units, outstanding	`CommonStockOtherSharesOutstanding`	240,000.00	shares	Point-in-time
Treasury stock, shares	`TreasuryStockShares`	12.24M	shares	Point-in-time
Inventories	`InventoryNet`	$183.76M	USD	Point-in-time
Inventories	`InventoryNet`	$188.83M	USD	Point-in-time
Treasury stock, shares	`TreasuryStockShares`	13.00M	shares	Point-in-time
Deferred income tax assets	`DeferredTaxAssetsNetCurrent`	$39.83M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$62.60M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$62.07M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$809.01M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$821.63M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$343.01M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$333.03M	USD	Point-in-time
Goodwill	`Goodwill`	$178.93M	USD	Point-in-time
Goodwill	`Goodwill`	$181.94M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$53.26M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$55.91M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$85.49M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$91.43M	USD	Point-in-time
Total long-term assets	`AssetsNoncurrent`	$669.64M	USD	Point-in-time
Total long-term assets	`AssetsNoncurrent`	$653.36M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.48B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.47B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$52.46M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$52.65M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$178.27M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$205.53M	USD	Point-in-time
Line of credit	`LinesOfCreditCurrent`	$622.00M	USD	Point-in-time
Line of credit	`LinesOfCreditCurrent`	$573.00M	USD	Point-in-time
Current portion of deferred revenue	`DeferredRevenueCurrent`	$25.58M	USD	Point-in-time
Current portion of deferred revenue	`DeferredRevenueCurrent`	$25.94M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$878.67M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$856.76M	USD	Point-in-time
Deferred income tax liabilities	`DeferredTaxLiabilitiesNoncurrent`	$49.39M	USD	Point-in-time
Deferred income tax liabilities	`DeferredTaxLiabilitiesNoncurrent`	$15.60M	USD	Point-in-time
Long-term debt	`SecuredLongTermDebt`	$600.02M	USD	Point-in-time
Long-term debt	`SecuredLongTermDebt`	$597.09M	USD	Point-in-time
Long-term deferred revenue, net of current portion	`DeferredRevenueNoncurrent`	$27.79M	USD	Point-in-time
Long-term deferred revenue, net of current portion	`DeferredRevenueNoncurrent`	$27.05M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$28.70M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$30.36M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$673.77M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$702.23M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.56B	USD	Point-in-time
Total liabilities	`Liabilities`	$1.55B	USD	Point-in-time
Commitments and Contingencies (Note 13)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 13)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 102,546 and 102,237 shares in 2016 and 2015, respectively	`CommonStockValue`	$10.26M	USD	Point-in-time
Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 102,546 and 102,237 shares in 2016 and 2015, respectively	`CommonStockValue`	$10.26M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$940.53M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$952.94M	USD	Point-in-time
Deferred stock units: Outstanding: 240 units in both 2016 and 2015	`CommonStockOtherValueOutstanding`	$5.41M	USD	Point-in-time
Deferred stock units: Outstanding: 240 units in both 2016 and 2015	`CommonStockOtherValueOutstanding`	$5.43M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$318.36M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$364.38M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-37.52M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-42.27M	USD	Point-in-time
Treasury stock, at cost: 13,000 and 12,242 shares in 2016 and 2015, respectively	`TreasuryStockValue`	$1.32B	USD	Point-in-time
Treasury stock, at cost: 13,000 and 12,242 shares in 2016 and 2015, respectively	`TreasuryStockValue`	$1.37B	USD	Point-in-time
Total IDEXX Laboratories, Inc. stockholders deficit	`StockholdersEquity`	$-84.12M	USD	Point-in-time
Total IDEXX Laboratories, Inc. stockholders deficit	`StockholdersEquity`	$-73.92M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$130.00K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$135.00K	USD	Point-in-time
Total stockholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-84.00M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-73.79M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS DEFICIT	`LiabilitiesAndStockholdersEquity`	$1.48B	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS DEFICIT	`LiabilitiesAndStockholdersEquity`	$1.47B	USD	Point-in-time

Income Statement 44 line items

Line Item	Tag	Value	Unit	Period
Product revenue	`SalesRevenueGoodsNet`	$232.10M	USD	1 Quarter
Product revenue	`SalesRevenueGoodsNet`	$249.06M	USD	1 Quarter
Service revenue	`SalesRevenueServicesNet`	$168.49M	USD	1 Quarter
Service revenue	`SalesRevenueServicesNet`	$150.37M	USD	1 Quarter
Total revenue	`SalesRevenueNet`	$382.48M	USD	1 Quarter
Total revenue	`SalesRevenueNet`	$417.55M	USD	1 Quarter
Cost of product revenue	`CostOfGoodsSold`	$83.37M	USD	1 Quarter
Cost of product revenue	`CostOfGoodsSold`	$97.63M	USD	1 Quarter
Cost of service revenue	`CostOfServices`	$83.56M	USD	1 Quarter
Cost of service revenue	`CostOfServices`	$92.38M	USD	1 Quarter
Total cost of revenue	`CostOfRevenue`	$166.93M	USD	1 Quarter
Total cost of revenue	`CostOfRevenue`	$190.01M	USD	1 Quarter
Gross profit	`GrossProfit`	$215.54M	USD	1 Quarter
Gross profit	`GrossProfit`	$227.54M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$75.14M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$79.83M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$49.30M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$42.60M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$24.62M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$25.01M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$72.80M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$73.79M	USD	1 Quarter
Interest expense	`InterestExpense`	$8.30M	USD	1 Quarter
Interest expense	`InterestExpense`	$6.30M	USD	1 Quarter
Interest income	`InterestAndOtherIncome`	$820.00K	USD	1 Quarter
Interest income	`InterestAndOtherIncome`	$425.00K	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$66.92M	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$66.31M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$20.35M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$20.28M	USD	1 Quarter
Net income	`ProfitLoss`	$46.58M	USD	1 Quarter
Net income	`ProfitLoss`	$46.02M	USD	1 Quarter
Less: Net income (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$6.00K	USD	1 Quarter
Less: Net income (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-16.00K	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$46.59M	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$46.02M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.51	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.49	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.49	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.51	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	94.28M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	89.92M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	90.84M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	95.52M	shares	1 Quarter

Cash Flow Statement 60 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$46.58M	USD	1 Quarter
Net income	`ProfitLoss`	$46.02M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$18.55M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$16.15M	USD	1 Quarter
Impairment charge	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$1.11M	USD	1 Quarter
Benefit of deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$2.52M	USD	1 Quarter
Benefit of deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$565.00K	USD	1 Quarter
Share-based compensation expense	`ShareBasedCompensation`	$4.92M	USD	1 Quarter
Share-based compensation expense	`ShareBasedCompensation`	$4.65M	USD	1 Quarter
Other	`OtherOperatingActivitiesCashFlowStatement`	$625.00K	USD	1 Quarter
Other	`OtherOperatingActivitiesCashFlowStatement`	$586.00K	USD	1 Quarter
Tax benefit from share-based compensation arrangements	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$2.06M	USD	1 Quarter
Tax benefit from share-based compensation arrangements	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$7.71M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$51.44M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$21.50M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$-1.76M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$10.14M	USD	1 Quarter
Other assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$10.75M	USD	1 Quarter
Other assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$27.52M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$-4.33M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$-1.80M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$637.00K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$1.15M	USD	1 Quarter
Net cash provided (used) by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-14.64M	USD	1 Quarter
Net cash provided (used) by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$23.23M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$21.91M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$23.02M	USD	1 Quarter
Purchase of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$72.08M	USD	1 Quarter
Purchase of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$140.45M	USD	1 Quarter
Proceeds from the sale and maturities of marketable securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$3.23M	USD	1 Quarter
Proceeds from the sale and maturities of marketable securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$70.19M	USD	1 Quarter
Acquisitions of a businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$383.00K	USD	1 Quarter
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-23.80M	USD	1 Quarter
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-160.62M	USD	1 Quarter
Borrowings on revolving credit facilities, net	`ProceedsFromRepaymentsOfOtherDebt`	$500.00K	USD	1 Quarter
Borrowings on revolving credit facilities, net	`ProceedsFromRepaymentsOfOtherDebt`	$49.00M	USD	1 Quarter
Debt issue costs	`PaymentsOfDebtIssuanceCosts`	$57.00K	USD	1 Quarter
Debt issue costs	`PaymentsOfDebtIssuanceCosts`	$90.00K	USD	1 Quarter
Issuance of long term debt	`ProceedsFromIssuanceOfLongTermDebt`	$150.00M	USD	1 Quarter
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$53.48M	USD	1 Quarter
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$133.65M	USD	1 Quarter
Proceeds from exercises of stock options and employee stock purchase plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$5.76M	USD	1 Quarter
Proceeds from exercises of stock options and employee stock purchase plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$12.32M	USD	1 Quarter
Payment of acquisition-related contingent consideration	`PaymentsOfMergerRelatedCostsFinancingActivities`	$2.08M	USD	1 Quarter
Tax benefit from share-based compensation arrangements	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$2.06M	USD	1 Quarter
Tax benefit from share-based compensation arrangements	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$7.71M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$36.80M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$1.20M	USD	1 Quarter
Net effect of changes in exchange rates on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-1.91M	USD	1 Quarter
Net effect of changes in exchange rates on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$3.33M	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$3.96M	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-140.38M	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$182.16M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$322.54M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$128.99M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$132.95M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$182.16M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$322.54M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$128.99M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$132.95M	USD	Point-in-time

Comprehensive Income 27 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$46.58M	USD	1 Quarter
Unrealized gain (loss) on investments, tax expense (benefit)	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$19.00K	USD	1 Quarter
Net income	`ProfitLoss`	$46.02M	USD	1 Quarter
Unrealized gain (loss) on investments, tax expense (benefit)	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$70.00K	USD	1 Quarter
Unrealized gain, tax expense	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$3.08M	USD	1 Quarter
Unrealized gain, tax expense	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$-1.44M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-20.23M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$6.02M	USD	1 Quarter
Reclassification adjustment for gains included in net income, tax expense	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax`	$1.25M	USD	1 Quarter
Reclassification adjustment for gains included in net income, tax expense	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax`	$170.00K	USD	1 Quarter
Unrealized gain on net investment hedge	`TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax`	$2.22M	USD	1 Quarter
Unrealized gain on investments, net of tax expense of $70 in 2016 and $19 in 2015	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$205.00K	USD	1 Quarter
Unrealized gain on investments, net of tax expense of $70 in 2016 and $19 in 2015	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$33.00K	USD	1 Quarter
Unrealized gain (loss), net of tax expense (benefit) of ($1,443) in 2016 and $3,082 in 2015	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$7.18M	USD	1 Quarter
Unrealized gain (loss), net of tax expense (benefit) of ($1,443) in 2016 and $3,082 in 2015	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$-3.27M	USD	1 Quarter
Less: reclassification adjustment for gains included in net income, net of tax expense of $170 in 2016 and $1,253 in 2015	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax`	$429.00K	USD	1 Quarter
Less: reclassification adjustment for gains included in net income, net of tax expense of $170 in 2016 and $1,253 in 2015	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax`	$2.96M	USD	1 Quarter
Unrealized gain (loss) on derivative instruments	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$4.22M	USD	1 Quarter
Unrealized gain (loss) on derivative instruments	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-3.69M	USD	1 Quarter
Other comprehensive gain (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-15.98M	USD	1 Quarter
Other comprehensive gain (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$4.75M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$50.77M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$30.60M	USD	1 Quarter
Less: comprehensive income (loss) attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-16.00K	USD	1 Quarter
Less: comprehensive income (loss) attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$6.00K	USD	1 Quarter
Comprehensive income attributable to IDEXX Laboratories, Inc.	`ComprehensiveIncomeNetOfTax`	$30.62M	USD	1 Quarter
Comprehensive income attributable to IDEXX Laboratories, Inc.	`ComprehensiveIncomeNetOfTax`	$50.77M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.